These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 9877110

  • 1. Maintenance hemodialysis in patients with HIV-associated nephropathy.
    Dave MB, Shabih K, Blum S.
    Clin Nephrol; 1998 Dec; 50(6):367-74. PubMed ID: 9877110
    [Abstract] [Full Text] [Related]

  • 2. Survival experience of peritoneal dialysis patients with human immunodeficiency virus: a 17-year retrospective study.
    Khanna R, Tachopoulou OA, Fein PA, Chattopadhyay J, Avram MM.
    Adv Perit Dial; 2005 Dec; 21():159-63. PubMed ID: 16686310
    [Abstract] [Full Text] [Related]

  • 3. Gender-specific differences in the natural history, clinical features, and socioeconomic status of HIV-infected patients: experience of a treatment centre in Vienna.
    Armbruster C, Kriwanek S, Vorbach H.
    Wien Klin Wochenschr; 2000 Sep 15; 112(17):754-60. PubMed ID: 11042904
    [Abstract] [Full Text] [Related]

  • 4. [Prevalence of HIV infection in dialysis patients: results of a national multicenter study].
    Poignet JL, Desassis JF, Chanton N, Litchinko MB, Zins B, Kolko A, Patte R, Sobel A.
    Nephrologie; 1999 Sep 15; 20(3):159-63. PubMed ID: 10418006
    [Abstract] [Full Text] [Related]

  • 5. Interruption of antiretroviral treatment in HIV-infected patients with preserved immune function is associated with a low rate of clinical progression: a prospective study by AIDS Clinical Trials Group 5170.
    Skiest DJ, Su Z, Havlir DV, Robertson KR, Coombs RW, Cain P, Peterson T, Krambrink A, Jahed N, McMahon D, Margolis DM, AIDS Clinical Trials Group 5170 Study Team.
    J Infect Dis; 2007 May 15; 195(10):1426-36. PubMed ID: 17436222
    [Abstract] [Full Text] [Related]

  • 6. HIV-associated monoclonal gammopathy: a retrospective analysis of 25 patients.
    Amara S, Dezube BJ, Cooley TP, Pantanowitz L, Aboulafia DM.
    Clin Infect Dis; 2006 Nov 01; 43(9):1198-205. PubMed ID: 17029142
    [Abstract] [Full Text] [Related]

  • 7. [The methods of therapy ESRD patients infected with the human immunodeficiency virus-HIV].
    Gozdowska J, Durlik M.
    Przegl Lek; 2008 Nov 01; 65(2):82-6. PubMed ID: 18663906
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Long-term survival of HIV-infected patients treated with highly active antiretroviral therapy in Serbia and Montenegro.
    Jevtović DO, Salemović D, Ranin J, Pesić I, Zerjav S, Djurković-Djaković O.
    HIV Med; 2007 Mar 01; 8(2):75-9. PubMed ID: 17352762
    [Abstract] [Full Text] [Related]

  • 10. Impact of tuberculosis on the course of HIV-infected patients with a high initial CD4 lymphocyte count.
    Mañas E, Pulido F, Peña JM, Rubio R, Gonzalez-García J, Costa R, Pérez-Rodríguez E, Del Palacio A.
    Int J Tuberc Lung Dis; 2004 Apr 01; 8(4):451-7. PubMed ID: 15141738
    [Abstract] [Full Text] [Related]

  • 11. Long-term prognosis of HIV-infected patients with Kaposi sarcoma treated with pegylated liposomal doxorubicin.
    Martín-Carbonero L, Palacios R, Valencia E, Saballs P, Sirera G, Santos I, Baldobí F, Alegre M, Goyenechea A, Pedreira J, González del Castillo J, Martínez-Lacasa J, Ocampo A, Alsina M, Santos J, Podzamczer D, González-Lahoz J, Caelyx/Kaposi's Sarcoma Spanish Group.
    Clin Infect Dis; 2008 Aug 01; 47(3):410-7. PubMed ID: 18582203
    [Abstract] [Full Text] [Related]

  • 12. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1993 Sep 01; 422():1-340. PubMed ID: 12616289
    [Abstract] [Full Text] [Related]

  • 13. Should absolute lymphocyte count be used as a surrogate marker for CD4+ count in patients with HIV/AIDS?
    Jibrin YB, Yusuph H, Garbati MA, Gashau W, Abja UM.
    Afr J Med Med Sci; 2006 Mar 01; 35(1):9-13. PubMed ID: 17209321
    [Abstract] [Full Text] [Related]

  • 14. Uremia therapy in patients with end-stage renal disease and human immunodeficiency virus infection: has the outcome changed in the 1990s?
    Ifudu O, Mayers JD, Matthew JJ, Macey LJ, Brezsnyak W, Reydel C, McClendon E, Surgrue T, Rao TK, Friedman EA.
    Am J Kidney Dis; 1997 Apr 01; 29(4):549-52. PubMed ID: 9100043
    [Abstract] [Full Text] [Related]

  • 15. Duration of end-stage renal disease and kidney transplant outcome.
    Goldfarb-Rumyantzev A, Hurdle JF, Scandling J, Wang Z, Baird B, Barenbaum L, Cheung AK.
    Nephrol Dial Transplant; 2005 Jan 01; 20(1):167-75. PubMed ID: 15546892
    [Abstract] [Full Text] [Related]

  • 16. Observations on a cohort of HIV-infected patients undergoing native renal biopsy.
    Berliner AR, Fine DM, Lucas GM, Rahman MH, Racusen LC, Scheel PJ, Atta MG.
    Am J Nephrol; 2008 Jan 01; 28(3):478-86. PubMed ID: 18176076
    [Abstract] [Full Text] [Related]

  • 17. [The prognostic markers of survival and progression in HIV-1 infection. A study of CD4+ lymphocytes, antigen p24 and viral load during 3 years in a cohort of 251 patients].
    Rubio Caballero M, Nogués Biau A, Falguera Sacrest M, Puig Ganau T, Lecha N, Rubio Rivas C.
    An Med Interna; 2000 Oct 01; 17(10):533-7. PubMed ID: 11109648
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.